SeaStar Medical Holding Corporation - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
ICU Nasdaq 3840 seastarmedical.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for SeaStar Medical Holding Corporation

ICU: Poster Presentations at AKI & CRRT 2026 Highlight SAVE Registry Data and SCD MOA - Apr 1st, 2026 4:35 am
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026 - Mar 30th, 2026 6:20 am
SeaStar Medical Holding Corp (ICU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Mar 25th, 2026 9:01 pm
SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - Mar 25th, 2026 2:05 pm
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026 - Mar 18th, 2026 2:05 pm
OTC Markets Hosts Virtual Investor Presentation with Eric Schlorff, CEO of SeaStar Medical, and David Bautz, PhD, Senior Analyst at Zacks SCR - Mar 17th, 2026 9:44 am
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing - Mar 13th, 2026 6:35 am
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th - Mar 10th, 2026 8:21 am
SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th - Mar 9th, 2026 6:35 am
SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI - Mar 5th, 2026 6:20 am
ICU: Publication Validates Real-World Clinical Impact of QUELIMMUNE™ in Pediatric AKI - Feb 11th, 2026 4:59 am
SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI) - Feb 9th, 2026 6:20 am
CEO Chat with Eric Schlorff, CEO of SeaStar Medical Holding Corporation - Feb 2nd, 2026 3:00 am
SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference - Jan 29th, 2026 6:25 am
ICU: Critical Care Innovation for AKI Patients; Initiating Coverage of SeaStar Medical Holding Corp. - Jan 13th, 2026 2:43 am
SeaStar Medical Announces 2026 Milestones - Jan 7th, 2026 6:13 am
SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference - Jan 6th, 2026 6:53 am
SeaStar Medical Announces 1-for-10 Reverse Split - Dec 23rd, 2025 2:25 pm
SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI - Dec 2nd, 2025 6:27 am
SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference - Nov 20th, 2025 7:52 am